Our quest for weight-reducing prescription drugs
our quest for weight-reducing prescription drugs
We humans are more susceptible to obesity than any other mammal. While this trait served a vital purpose in pre-agricultural times, it has evolved into a significant public health issue in modern societies. Developing pharmacological therapies for obesity has been a formidable challenge, marked by numerous ineffective and sometimes hazardous interventions. However, Ozempic, a pioneering drug belonging to the GLP-1 agonist class, has recently emerged as a safe and effective approach to weight reduction. In this science café discussion, we’ll delve into why Ozempic works, how Ozempic works, and whether it lives up to the unprecedented hype.
Dr. Gergö Szanda is our presenter this month. Dr. Szanda is a Gill Center Research Scientist